A research team in China has identified two proteins present in the blood that may serve as potential bio-markers in people with colon cancer, for accurately predicting whether the disease will spread.
Surgery is the main method of treating the disease. However, half of colon cancer patients undergoing surgery develop a recurrence of the disease within five years due to its spread, or metastasis, to other parts of the body.
People With Genetic Predictors of Colorectal Cancer are Not Getting Screened
Even when diagnosed with a condition that is a strong genetic predictor of colorectal cancer, many patients do not seek out genetic counseling or cancer screening.
Even when diagnosed with a condition that is a strong genetic predictor of colorectal cancer, many patients do not seek out genetic counseling or cancer screening.
In an effort to identify useful bio-markers for tracking the spread of colon cancer, Maode Lai and colleagues compared proteins produced by primary, or original, tumor cells to those of metastasized cells came from a single individual with colon cancer.
They identified two proteins that occurred at significantly higher levels in the metastatic cells than in the primary cancer cells.
Social Factors Not Genetics Drive Racial Disparities in Colorectal Cancer Survival
Correcting social, economic and healthcare inequalities may have the most significant impact in reducing survival differences in colorectal cancer
Correcting social, economic and healthcare inequalities may have the most significant impact in reducing survival differences in colorectal cancer
The study has been published in ACS' Journal of Proteome Research, a monthly publication.
Advertisement
Colorectal Cancer Screening Could Cut Costs Even as Treatment Costs Increase
A new study in the Journal of the National Cancer Institute has revealed that investing in some colorectal cancer screening programs could cut expensive treatment costs
A new study in the Journal of the National Cancer Institute has revealed that investing in some colorectal cancer screening programs could cut expensive treatment costs
TRI
Researchers Moot Cost-Effective Strategy to Screen Second Primary Colorectal Cancers
A research group has constructed a decision-analytic model and compared cost-effectiveness results of cancer screening in male cancer survivors for second primary colorectal cancer screening
A research group has constructed a decision-analytic model and compared cost-effectiveness results of cancer screening in male cancer survivors for second primary colorectal cancer screening
